Alpha 1 Antitrypsin therapy in patients with Alpha 1 Antitrypsin deficiency: perspectives from a registry study and practical considerations for self-administration during the COVID-19 pandemic
The challenges of providing alpha 1 antitrypsin therapy during the COVID-19 pandemic and the potential considerations for its implementation thereafter
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 November 2021
|
| In: |
The International journal of chronic obstructive pulmonary disease
Year: 2021, Jahrgang: 16, Pages: 2983-2996 |
| ISSN: | 1178-2005 |
| DOI: | 10.2147/COPD.S325211 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/COPD.S325211 Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/alpha-1-antitrypsin-therapy-in-patients-with-alpha-1-antitrypsin-defic-peer-reviewed-fulltext-article-COPD 
|
| Verfasserangaben: | Felix JF Herth, Robert A. Sandhaus, Alice M. Turner, Maria Sucena, Tobias Welte, Timm Greulich |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1817979523 | ||
| 003 | DE-627 | ||
| 005 | 20230426141111.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221004s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/COPD.S325211 |2 doi | |
| 035 | |a (DE-627)1817979523 | ||
| 035 | |a (DE-599)KXP1817979523 | ||
| 035 | |a (OCoLC)1361714158 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Herth, Felix |e VerfasserIn |0 (DE-588)1016095236 |0 (DE-627)705477568 |0 (DE-576)351509925 |4 aut | |
| 245 | 1 | 0 | |a Alpha 1 Antitrypsin therapy in patients with Alpha 1 Antitrypsin deficiency |b perspectives from a registry study and practical considerations for self-administration during the COVID-19 pandemic |c Felix JF Herth, Robert A. Sandhaus, Alice M. Turner, Maria Sucena, Tobias Welte, Timm Greulich |
| 264 | 1 | |c 1 November 2021 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.10.2022 | ||
| 520 | |a The challenges of providing alpha 1 antitrypsin therapy during the COVID-19 pandemic and the potential considerations for its implementation thereafter | ||
| 700 | 1 | |a Sandhaus, Robert A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Turner, Alice M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sucena, Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Welte, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Greulich, Timm |d 1975- |e VerfasserIn |0 (DE-588)129997811 |0 (DE-627)486914372 |0 (DE-576)297942158 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The International journal of chronic obstructive pulmonary disease |d Albany, Auckland : DOVE Medical Press, 2006 |g 16(2021), Seite 2983-2996 |h Online-Ressource |w (DE-627)504104357 |w (DE-600)2212419-6 |w (DE-576)312706367 |x 1178-2005 |7 nnas |a Alpha 1 Antitrypsin therapy in patients with Alpha 1 Antitrypsin deficiency perspectives from a registry study and practical considerations for self-administration during the COVID-19 pandemic |
| 773 | 1 | 8 | |g volume:16 |g year:2021 |g pages:2983-2996 |g extent:14 |a Alpha 1 Antitrypsin therapy in patients with Alpha 1 Antitrypsin deficiency perspectives from a registry study and practical considerations for self-administration during the COVID-19 pandemic |
| 856 | 4 | 0 | |u https://doi.org/10.2147/COPD.S325211 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.dovepress.com/alpha-1-antitrypsin-therapy-in-patients-with-alpha-1-antitrypsin-defic-peer-reviewed-fulltext-article-COPD |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221004 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1016095236 |a Herth, Felix |m 1016095236:Herth, Felix |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PH1016095236 |e 950000PH1016095236 |e 950900PH1016095236 |e 50000PH1016095236 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1817979523 |e 4194292251 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Felix JF Herth, Robert A. Sandhaus, Alice M. Turner, Maria Sucena, Tobias Welte, Timm Greulich"]},"id":{"eki":["1817979523"],"doi":["10.2147/COPD.S325211"]},"person":[{"family":"Herth","role":"aut","given":"Felix","display":"Herth, Felix"},{"family":"Sandhaus","role":"aut","given":"Robert A.","display":"Sandhaus, Robert A."},{"display":"Turner, Alice M.","role":"aut","given":"Alice M.","family":"Turner"},{"display":"Sucena, Maria","role":"aut","given":"Maria","family":"Sucena"},{"display":"Welte, Tobias","given":"Tobias","role":"aut","family":"Welte"},{"role":"aut","given":"Timm","family":"Greulich","display":"Greulich, Timm"}],"relHost":[{"id":{"zdb":["2212419-6"],"issn":["1178-2005"],"eki":["504104357"]},"part":{"volume":"16","text":"16(2021), Seite 2983-2996","extent":"14","pages":"2983-2996","year":"2021"},"titleAlt":[{"title":"International journal of COPD"}],"pubHistory":["1.2006 -"],"title":[{"title_sort":"International journal of chronic obstructive pulmonary disease","title":"The International journal of chronic obstructive pulmonary disease"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 02.11.09"],"origin":[{"publisher":"DOVE Medical Press","publisherPlace":"Albany, Auckland","dateIssuedKey":"2006","dateIssuedDisp":"2006-"}],"disp":"Alpha 1 Antitrypsin therapy in patients with Alpha 1 Antitrypsin deficiency perspectives from a registry study and practical considerations for self-administration during the COVID-19 pandemicThe International journal of chronic obstructive pulmonary disease","recId":"504104357","physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"1 November 2021"}],"title":[{"subtitle":"perspectives from a registry study and practical considerations for self-administration during the COVID-19 pandemic","title":"Alpha 1 Antitrypsin therapy in patients with Alpha 1 Antitrypsin deficiency","title_sort":"Alpha 1 Antitrypsin therapy in patients with Alpha 1 Antitrypsin deficiency"}],"note":["Gesehen am 04.10.2022"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1817979523","physDesc":[{"extent":"14 S."}]} | ||
| SRT | |a HERTHFELIXALPHA1ANTI1202 | ||